VIVE
Income statement / Annual
Last year (2021), Viveve Medical, Inc.'s total revenue was $6.43 M,
an increase of 17.28% from the previous year.
In 2021, Viveve Medical, Inc.'s net income was -$22.03 M.
See Viveve Medical, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$6.43 M
|
$5.48 M
|
$6.57 M
|
$18.52 M
|
$15.29 M
|
$7.14 M
|
$1.45 M
|
$90,000.00
|
$1.27 M
|
$1.08 M
|
| Cost of Revenue |
$5.81 M |
$5.18 M |
$5.55 M |
$11.20 M |
$7.84 M |
$4.61 M |
$985,000.00 |
$50,000.00 |
$531,000.00 |
$541,000.00 |
| Gross Profit |
$620,000.00 |
$296,000.00 |
$1.02 M |
$7.32 M |
$7.44 M |
$2.53 M |
$462,000.00 |
$40,000.00 |
$743,000.00 |
$539,000.00 |
| Gross Profit Ratio |
0.1 |
0.05 |
0.15 |
0.4 |
0.49 |
0.35 |
0.32 |
0.44 |
0.58 |
0.5 |
| Research and Development
Expenses |
$9.67 M
|
$5.13 M
|
$8.59 M
|
$13.72 M
|
$12.34 M
|
$8.37 M
|
$4.99 M
|
$1.43 M
|
$2.12 M
|
$2.03 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$12.51 M
|
$13.67 M
|
$22.36 M
|
$38.57 M
|
$28.83 M
|
$12.87 M
|
$7.46 M
|
$4.28 M
|
$3.33 M
|
$2.63 M
|
| Other Expenses |
$0.00 |
-$289,000.00 |
-$161,000.00 |
$13,000.00 |
$0.00 |
$0.00 |
$0.00 |
$49,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$22.17 M |
$18.79 M |
$30.95 M |
$52.29 M |
$41.17 M |
$21.23 M |
$12.45 M |
$5.70 M |
$5.45 M |
$4.66 M |
| Cost And Expenses |
$27.98 M |
$23.97 M |
$36.50 M |
$63.48 M |
$49.02 M |
$25.85 M |
$13.44 M |
$5.75 M |
$5.98 M |
$5.21 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$80,000.00 |
| Interest Expense |
$1.00 M |
$910,000.00 |
$4.35 M |
$4.37 M |
$3.17 M |
$1.37 M |
$415,000.00 |
$567,000.00 |
$337,000.00 |
$555,000.00 |
| Depreciation &
Amortization |
$1.14 M
|
$1.30 M
|
$1.18 M
|
$786,000.00
|
$449,000.00
|
$111,000.00
|
$77,000.00
|
$56,000.00
|
$53,000.00
|
$43,000.00
|
| EBITDA |
-$19.63 M
|
-$18.50 M
|
-$30.68 M
|
-$44.17 M
|
-$33.34 M
|
-$18.63 M
|
-$11.93 M
|
-$5.66 M
|
-$4.65 M
|
-$4.08 M
|
| EBITDA Ratio |
-3.06 |
-3.43 |
-4.4 |
-2.43 |
-2.2 |
-2.62 |
-8.29 |
-61.74 |
-3.65 |
-3.78 |
| Operating Income Ratio
|
-3.35
|
-3.38
|
-4.56
|
-2.43
|
-2.21
|
-2.62
|
-8.29
|
-62.91
|
-3.69
|
-3.82
|
| Total Other
Income/Expenses Net |
-$218,000.00
|
-$3.04 M
|
-$11.22 M
|
-$4.36 M
|
-$3.23 M
|
-$1.41 M
|
-$436,000.00
|
-$518,000.00
|
$8.20 M
|
-$4.26 M
|
| Income Before Tax |
-$21.77 M |
-$21.53 M |
-$41.90 M |
-$49.32 M |
-$36.96 M |
-$20.11 M |
-$12.43 M |
-$6.18 M |
$3.50 M |
-$8.39 M |
| Income Before Tax Ratio
|
-3.39
|
-3.93
|
-6.38
|
-2.66
|
-2.42
|
-2.82
|
-8.59
|
-68.67
|
2.75
|
-7.77
|
| Income Tax Expense |
$256,000.00 |
-$293,000.00 |
$4.82 M |
-$142,000.00 |
-$329,000.00 |
$1.26 M |
$338,000.00 |
$616,000.00 |
$337,000.00 |
$555,000.00 |
| Net Income |
-$22.03 M |
-$21.24 M |
-$46.72 M |
-$49.18 M |
-$36.63 M |
-$20.11 M |
-$12.43 M |
-$6.18 M |
$3.50 M |
-$8.39 M |
| Net Income Ratio |
-3.43 |
-3.88 |
-7.11 |
-2.66 |
-2.4 |
-2.82 |
-8.59 |
-68.67 |
2.75 |
-7.77 |
| EPS |
-2.65 |
-13.5 |
-374.4 |
-1583.5 |
-2093.62 |
-2180.76 |
-2474.31 |
-2744.23 |
22429 |
-209675 |
| EPS Diluted |
-2.65 |
-13.5 |
-374.4 |
-1583.5 |
-2093.62 |
-2180.76 |
-2474.31 |
-2744.23 |
22429 |
-209675 |
| Weighted Average Shares
Out |
$10.09 M
|
$1.57 M
|
$124,784.00
|
$31,059.00
|
$17,496.00
|
$9,222.00
|
$5,022.00
|
$2,252.00
|
$156.00
|
$40.00
|
| Weighted Average Shares
Out Diluted |
$10.09 M
|
$1.57 M
|
$124,784.00
|
$31,059.00
|
$17,496.00
|
$9,222.00
|
$5,022.00
|
$2,252.00
|
$156.00
|
$40.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
